After Reuters reported that Bai, the seller of antioxidant infusion drinks that is allied with Dr Pepper Snapple and in which the beverage company has a minority equity investment, is exploring a potential sale, Bernstein analyst Ali Dibadj said the firm's analysis suggests that the loss of Bai from Dr Pepper's system could result in a meaningful 100 basis point drag on the company's top line. Allied brands distributed by Dr. Pepper, like Bai, have been driving at least half of its topline growth recently, added Dibadj, who keeps a Market Perform rating on the stock.